These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8575032)

  • 21. Response heterogeneity of 5-HT3 receptor antagonists in a rat visceral hypersensitivity model.
    Langlois A; Pascaud X; Junien JL; Dahl SG; Rivière PJ
    Eur J Pharmacol; 1996 Dec; 318(1):141-4. PubMed ID: 9007525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. Synthesis and structure-activity relationships of 9-methyl-2,3,4,9-tetrahydrothiopyrano[2,3-b]indol-4-one derivatives.
    Suzuki T; Matsuhisa A; Miyata K; Yanagisawa I; Ohta M
    Chem Pharm Bull (Tokyo); 1997 Jan; 45(1):101-6. PubMed ID: 9023971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New 5-HT3 (serotonin-3) receptor antagonists, II. Synthesis and structure-activity relationships of pyrimido[1,6-a]indoles.
    Kato M; Nishino S; Ito K; Yamakuni H; Takasugi H
    Chem Pharm Bull (Tokyo); 1994 Dec; 42(12):2556-64. PubMed ID: 7697772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists.
    Rosen T; Nagel AA; Rizzi JP; Ives JL; Daffeh JB; Ganong AH; Guarino K; Heym J; McLean S; Nowakowski JT
    J Med Chem; 1990 Oct; 33(10):2715-20. PubMed ID: 2213824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors.
    Cappelli A; Anzini M; Vomero S; Canullo L; Mennuni L; Makovec F; Doucet E; Hamon M; Menziani MC; De Benedetti PG; Bruni G; Romeo MR; Giorgi G; Donati A
    J Med Chem; 1999 May; 42(9):1556-75. PubMed ID: 10229626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel series of N-(hexahydro-1,4-diazepin-6-yl) and N-(hexahydroazepin- 3-yl)benzamides with high affinity for 5-HT3 and dopamine D2 receptors.
    Hirokawa Y; Morie T; Yamazaki H; Yoshida N; Kato S
    Bioorg Med Chem Lett; 1998 Mar; 8(6):619-24. PubMed ID: 9871571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized rats.
    Miyata K; Kamato T; Yamano M; Nishida A; Ito H; Katsuyama Y; Yuki H; Tsutsumi R; Ohta M; Takeda M
    J Pharmacol Exp Ther; 1991 Nov; 259(2):815-9. PubMed ID: 1941629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)nicotinamides and their affinities for 5-HT3 and dopamine D2 receptors.
    Hirokawa Y; Yoshida N; Kato S
    Bioorg Med Chem Lett; 1998 Jun; 8(12):1551-4. PubMed ID: 9873388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New 2-piperazinylbenzimidazole derivatives as 5-HT3 antagonists. Synthesis and pharmacological evaluation.
    Orjales A; Mosquera R; Labeaga L; Rodes R
    J Med Chem; 1997 Feb; 40(4):586-93. PubMed ID: 9046349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and structure-activity relationships of 2,3-dihydrobenzofuran-7-carboxamide derivatives as potent serotonin-3 (5-HT3) receptor antagonists.
    Kuroita T; Yasumoto M; Inaba K; Sakamori M; Takehara S; Kawakita T
    Chem Pharm Bull (Tokyo); 1994 Jan; 42(1):95-100. PubMed ID: 8124772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycinergic potentiation by some 5-HT(3) receptor antagonists: insight into selectivity.
    Chesnoy-Marchais D; Lévi S; Acher F
    Eur J Pharmacol; 2000 Aug; 402(3):205-13. PubMed ID: 10958886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
    Endo T; Minami M; Kitamura N; Teramoto Y; Ogawa T; Nemoto M; Hamaue N; Hirafuji M; Yasuda E; Blower PR
    Res Commun Mol Pathol Pharmacol; 1999; 104(2):145-55. PubMed ID: 10634307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-HT3 receptor antagonist effects of DAT-582, (R) enantiomer of AS-5370.
    Yoshida N; Omoya H; Kato S; Ito T
    Eur J Pharmacol; 1992 Jun; 216(3):435-40. PubMed ID: 1425931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.
    Vernekar SK; Hallaq HY; Clarkson G; Thompson AJ; Silvestri L; Lummis SC; Lochner M
    J Med Chem; 2010 Mar; 53(5):2324-8. PubMed ID: 20146481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New benzimidazole derivatives: selective and orally active 5-HT3 receptor antagonists.
    Pascual D; Girón R; Alsasua A; Benhamú B; López-Rodríguez ML; Martín MI
    Eur J Pharmacol; 2003 Feb; 462(1-3):99-107. PubMed ID: 12591101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. IV. Synthesis and pharmacological evaluation of the oxidation products of (-)-(R)-5-[(1-methyl-1H-indol-3-yl)carbonyl] -4,5,6,7-tetrahydro-1H-benzimidazole hydrochloride (YM060: ramosetron).
    Ohta M; Suzuki T; Nagashima S; Tokunaga T; Miyata K; Mase T
    Chem Pharm Bull (Tokyo); 1996 Sep; 44(9):1717-22. PubMed ID: 8855366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An efficient synthesis of 5-bromo-2-methoxy-6-methylaminopyridine-3carboxylic acid.
    Hirokawa Y; Horikawa T; Kato S
    Chem Pharm Bull (Tokyo); 2000 Dec; 48(12):1847-53. PubMed ID: 11145130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and 5-HT3 receptor affinity of new quinolinecarboxylic acid derivatives.
    Orjales A; Alonso-Cires L; López-Tudanca PL; Tapia I; Labeaga L; Mosquera R
    Drug Des Discov; 2000; 16(4):271-9. PubMed ID: 10807033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.